Condition
Progressive Oligodendroglioma
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
4 treatments under study, led by Td Vaccine
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 1 (1)
Trial Status
Recruiting1
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Td Vaccine1
- Ttrnaxalt1
- Ttrnadc Vaccines With Gmcsf1
- Autologous Hematopoietic Stem Cells Hscs1
Active Sponsors
- Oligo Nation, Inc1
- University of Florida1
Top Investigators
University of Florida
University of Florida
Related Conditions
- Recurrent Oligodendroglioma1